74 related articles for article (PubMed ID: 3100594)
1. Cost effectiveness of prevaccination screening for hepatitis B antibody.
Jacobson JJ; La Turno DE; Johnston FK; Shipman C
J Dent Educ; 1987 Feb; 51(2):94-7. PubMed ID: 3100594
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of screening for only anti-HBc in institutions for mentally retarded persons.
Akhter MN; Van Tiunen M; Metzger R; Goins J
Am J Ment Retard; 1987 Nov; 92(3):279-81. PubMed ID: 3122797
[TBL] [Abstract][Full Text] [Related]
3. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
Zhang SX
Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
[TBL] [Abstract][Full Text] [Related]
4. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
Mulley AG; Silverstein MD; Dienstag JL
N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness study of prevaccination screening tests in vaccination against hepatitis B in hospital health professionals].
Guillén Grima F; Aguinaga Ontoso I
Med Clin (Barc); 1992 Sep; 99(9):327-8. PubMed ID: 1434999
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of hepatitis B vaccination.
Jönsson B
Postgrad Med J; 1987; 63 Suppl 2():27-32. PubMed ID: 3120169
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of hepatitis B screening in a mental health institution.
Leonard J; Holtgrave DR; Johnson RP
J Fam Pract; 1991 Jan; 32(1):45-8. PubMed ID: 1824638
[TBL] [Abstract][Full Text] [Related]
8. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
9. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
Plans-Rubió P
Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
11. Cost-effective analysis of hepatitis A prevention in Ireland.
Rajan E; Shattock AG; Fielding JF
Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease.
El-Karaksy H; El-Sayed R; El-Raziky M; El-Koofy N; Mansour S
East Mediterr Health J; 2008; 14(4):804-9. PubMed ID: 19166163
[TBL] [Abstract][Full Text] [Related]
13. A successful hepatitis B immunization program in a dental school.
Platt D; Langkamp HH; Bowen PA; Wright B
J Dent Educ; 1988 Feb; 52(2):121-2. PubMed ID: 2963044
[No Abstract] [Full Text] [Related]
14. A cost comparison analysis for screening and vaccination of hospital personnel with high- and low-prevalence hepatitis B virus antibodies in California.
Tong MJ; Co RL; Marci RD; Michaelson PM; Ortega G
Infect Control Hosp Epidemiol; 1988 Feb; 9(2):66-71. PubMed ID: 3125243
[TBL] [Abstract][Full Text] [Related]
15. [Molecular biology and serologic analysis in an epidemic of viral hepatitis B in vaccinated patients on hemodialysis].
Nĕmecek V; Reinis M; Konopácová A; Summerová M; König J; Kubánek J
Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):160-6. PubMed ID: 10658344
[TBL] [Abstract][Full Text] [Related]
16. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
Reintjes R; Bosman A; de Zwart O
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
[TBL] [Abstract][Full Text] [Related]
18. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
19. [Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum].
Vrijmoeth P; Heijtink RA; Schreuder H; Kroes AC
Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1694-7. PubMed ID: 9543786
[TBL] [Abstract][Full Text] [Related]
20. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
